Barclays Maintains Overweight on Eli Lilly, Raises Price Target to $1550

Benzinga · 2d ago
Barclays analyst Emily Field maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1400 to $1550.